Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
about
Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedemaTopical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a reviewProstaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.Ocular pharmacokinetics of 0.45% ketorolac tromethamineNonsteroidal anti-inflammatory drugs for retinal disease.Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgeryTopical nonsteroidal anti-inflammatory drugs for macular edema.Inflammation and macular oedema after pars plana vitrectomy.Efficacy and vitreous levels of topical NSAIDs.Alternative Drug Delivery for Patients Undergoing Cataract Surgery as Demonstrated in a Canine Model.A randomised controlled trial of ranibizumab with and without ketorolac eyedrops for exudative age-related macular degeneration.The Effect of Perioperative Topical Ketorolac 0.5% on Macular Thickness after Uneventful Phacoemulsification.
P2860
Q24188127-1DD48192-F598-42FA-899A-0F9F96C50057Q28077419-53740967-6685-44FF-AED6-E5C3F04FB0FFQ34079832-4C4BF12A-5DFF-4FB8-ACA4-679AE5497D1FQ34393044-4882B2F8-80CD-482C-8956-2CEBC3C66671Q36567310-8BA68D8C-EC5B-4F9D-B583-9C1D40BDB961Q37900493-70636318-5215-4CC4-8873-C161426E1478Q38162433-F933BD0F-DC47-4B49-B3C8-6D7611522797Q38167310-48084367-15F6-46FE-84EE-C7CD325FFAD0Q38546915-C30A9B9E-033C-4358-ABC7-882E33A74473Q46545095-1D10B8D9-BBF5-4279-B9DB-F6E0A2915E87Q47965322-E3D12EB4-C332-4B17-BCA0-AEE524E05E73Q48246916-E495E1F5-CBBF-495A-AFF7-01A58945BBAD
P2860
Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@ast
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@en
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@nl
type
label
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@ast
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@en
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@nl
prefLabel
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@ast
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@en
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@nl
P2093
P1433
P1476
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@en
P2093
Brandon G Busbee
Carl C Awh
Glenn L Stoller
Jeffrey S Heier
L David Waterbury
Paul Daniel
Tina S Cleary
P304
P356
10.1097/IAE.0B013E3181B094E6
P577
2009-10-01T00:00:00Z